(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-1.31%) $82.75
(6.29%) $2.04
(0.03%) $2 347.90
(-0.23%) $27.47
(3.87%) $957.75
(-0.22%) $0.933
(-0.36%) $10.99
(-0.55%) $0.796
(1.67%) $93.40
-2.41% £ 40.50
Live Chart Being Loaded With Signals
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally...
Stats | |
---|---|
Dzisiejszy wolumen | 216 849 |
Średni wolumen | 215 038 |
Kapitalizacja rynkowa | 51.23M |
EPS | £0 ( 2024-04-11 ) |
Last Dividend | £0.0400 ( 2018-05-24 ) |
Next Dividend | £0 ( N/A ) |
P/E | 40.50 |
ATR14 | £0.452 (1.11%) |
Venture Life Group PLC Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Venture Life Group PLC Finanse
Annual | 2023 |
Przychody: | £51.41M |
Zysk brutto: | £13.51M (26.27 %) |
EPS: | £0.00730 |
FY | 2023 |
Przychody: | £51.41M |
Zysk brutto: | £13.51M (26.27 %) |
EPS: | £0.00730 |
FY | 2022 |
Przychody: | £43.98M |
Zysk brutto: | £17.67M (40.17 %) |
EPS: | £0.00410 |
FY | 2021 |
Przychody: | £32.76M |
Zysk brutto: | £12.96M (39.55 %) |
EPS: | £0.0278 |
Financial Reports:
No articles found.
Venture Life Group PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
First Dividend | £0.0400 | 2014-06-11 |
Last Dividend | £0.0400 | 2018-05-24 |
Next Dividend | £0 | N/A |
Payout Date | 2018-06-22 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | £0.200 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.4 | -- |
Div. Sustainability Score | 8.11 | |
Div.Growth Potential Score | 4.20 | |
Div. Directional Score | 6.15 | -- |
Year | Amount | Yield |
---|---|---|
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £0.0400 | 0.10% |
2019 | £0 | 0.00% |
2020 | £0 | 0.00% |
2021 | £0 | 0.00% |
2022 | £0 | 0.00% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
WTB.L | Dividend Knight | 2023-05-25 | Annually | 33 | 0.87% | |
NTV.L | Dividend Knight | 2023-07-20 | Semi-Annually | 25 | 4.03% | |
EMG.L | Dividend King | 2023-08-10 | Semi-Annually | 31 | 3.60% | |
SPT.L | Dividend Knight | 2023-08-10 | Semi-Annually | 32 | 1.51% | |
JD.L | Dividend Knight | 2023-12-07 | Annually | 28 | 0.21% | |
BUT.L | Dividend King | 2023-08-03 | Quarterly | 49 | 1.28% | |
PNL.L | Dividend Knight | 2023-08-24 | Quarterly | 41 | 0.75% | |
FSFL.L | Dividend Knight | 2023-07-20 | Quarterly | 11 | 3.85% | |
AERI.L | Dividend Junior | 2023-08-17 | Quarterly | 6 | 2.80% | |
THRG.L | Dividend Knight | 2023-08-03 | Semi-Annually | 52 | 1.02% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0179 | 1.500 | 9.64 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.00771 | 1.200 | 9.74 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0123 | 1.500 | -0.975 | -1.462 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.084 | 0.800 | 9.58 | 7.67 | [1 - 3] |
quickRatioTTM | 0.735 | 0.800 | -0.380 | -0.304 | [0.8 - 2.5] |
cashRatioTTM | 0.189 | 1.500 | -0.0587 | -0.0880 | [0.2 - 2] |
debtRatioTTM | 0.204 | -1.500 | 6.60 | -9.90 | [0 - 0.6] |
interestCoverageTTM | 3.00 | 1.000 | -0.00174 | -0.00174 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0540 | 2.00 | 9.98 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0350 | 2.00 | 9.98 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.320 | -1.500 | 8.72 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.263 | 1.000 | 8.95 | 8.95 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0865 | 1.000 | -0.271 | -0.271 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.280 | 1.000 | 9.56 | 9.56 | [0.2 - 2] |
assetTurnoverTTM | 0.430 | 0.800 | -0.465 | -0.372 | [0.5 - 2] |
Total Score | 8.11 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 57.00 | 1.000 | 4.34 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0123 | 2.50 | -0.627 | -1.462 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0350 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0540 | 2.00 | 9.98 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 77.45 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.133 | 1.000 | 9.18 | 0 | [0.1 - 0.5] |
Total Score | 4.20 |
Venture Life Group PLC
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. It operates through Venture Life Brands and Customer Brands segments. The company offers neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance alertness, cognitive function, and mental performance in healthy brain; and Original Bioscalin to treat and prevent hair loss, hair thinning, and baldness. It also provides Fungal Nail Solution, which helps to treat and prevent fungal infections; and Fungal Nail Cleanser for the hygiene of hands and feet prone to fungal nail infections under the Myco Clear brand name. In addition, the company offers UltraDEX product for bad breath; Dently Dual Action, a mouthwash, which lifts and removes plaque and bacteria from the teeth and gums; and Procto-eze plus for anal irritation, including haemorrhoids condition. Further, it provides women healthcare products comprising vonalei bacterial vaginosis, a refreshing gel; vonalei Vaginal Atrophy, a vaginal cream; vonalei candidiasis, a soothing cream-gel for thrush; and vonalei intimate cleansing foam. Additionally, it offers Cleansing Foam, Cleansing Cream, and Serum under the Rosa calma brand name; and skincare ranges to hydrate, nourish, and recondition the skin, as well as to prevent the lines and wrinkles under the Lubatti Classic and the Lubatti Anti-age brand names. The company sells its products through a network of international partners, retail pharmacies, as well as grocery multiple retailers. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej